Dxcover

Dxcover, a spin-out from the University of Strathclyde, is pioneering a new blood test for the early detection of brain, colorectal and lung cancer.

Formerly known as Clinspec Dx and Co-founded by Dr Holly Butler, a postdoctoral research associate at the University of Strathclyde, the company uses revolutionary technology to provide accurate results in minutes.

To date the company has raised over £14 million of investment and grants, helping to grow its team from 4 to 20 in just four years, and initiating three pivotal clinical trials with the hope of commercialising the test by 2025.

Currently based in Scotland, the company is expanding its network in Europe and the USA.

To find out more, check out the video below: